Saltar al contenido

1478833

USP

Orlistat Related Compound C

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

Triphenylphosphine oxide, Ph3PO, TPPO, Triphenyl phosphorus oxide, Triphenylphosphine monoxide

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

Fórmula lineal:
(C6H5)3PO
Número CAS:
Peso molecular:
278.28
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
745854
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


grade

pharmaceutical primary standard

agency

USP

API family

orlistat

form

crystalline

manufacturer/tradename

USP

mp

150-157 °C (lit.)

application(s)

USP Biologics
pharmaceutical
pharmaceutical (small molecule)

format

neat

SMILES string

O=P(c1ccccc1)(c2ccccc2)c3ccccc3

InChI

1S/C18H15OP/c19-20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H

InChI key

FIQMHBFVRAXMOP-UHFFFAOYSA-N

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Orlistat Related Compound C is a chemical impurity related to the active pharmaceutical ingredient Orlistat. It is a by-product that can be formed during the synthesis of Orlistat and is closely monitored in biologic formulations. The presence of this compound is typically controlled, as it may impact the safety, efficacy, and regulatory compliance of the final product.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Orlistat Related Compound C USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Latanoprost
  • Orlistat

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.
This product is part of USP Biologics Program.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.


Still not finding the right product?

Explore all of our products under Orlistat Related Compound C


Pictogramas

Exclamation mark

Palabra de advertencia

Warning

Códigos de peligro

Indicaciones de precaución

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3

Clase de almacenamiento

11 - Combustible Solids

¿Qué está pasando?

WGK 2

Punto de inflamación (°F)

Not applicable

Punto de inflamación (°C)

Not applicable



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos